Thought Leadership
Read our insights and commentary about industry news and innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 3 of 88 posts
May 7, 2020 | Podcasts
CBPartners’ Pharma Take-Away: AMARIN’s VASCEPA patent loss: is it obvious(ness)?
Patent management is the hot topic of this episode. The focus is on AMARIN’s leading product, VASCEPA, a drug made up of natural derivatives such as fish oil and was approved by the FDA in December 2019.
May 5, 2020 | Podcasts
Speaking of Access: Pricing for Uncertain Indications
Andrew Gould asks our US payer panel for their expert perspectives surrounding pricing for uncertain future indications.
April 30, 2020 | Culture Blog, News
cbpGIVES Raises $4,150 Within the Firm to Support COVID-19 Relief Efforts
The global COVID-19 crisis has affected many individuals worldwide in substantial ways, including increasing food insecurity, medical burden and economic loss. CBPartners' charitable faction cbpGIVES coordinated efforts firm-wide to raise funds to support COVID-19 relief. CBPartners has matched every dollar raised by employees and have raised a total of $4,150 to donate to several organizations across the world.